Rare diseases
Investigational molecules
Locations
Ettlinger Strasse 5a, Suedstadt, 76137 Karlsruhe, Germany
Siteworks GmbH in Karlsruhe, Germany specialises in clinical trials of conditions such as Overweight, Obesity, Obstructive sleep apnoea syndrome, Osteoarthritis, and other specialisations. This site conducts important research.
At Siteworks GmbH investigators are exploring innovative approaches to reduce cardiovascular risk in patients with obesity and related conditions.
These studies aim to test new therapies that lower LDL‑C, improve heart outcomes, and support weight management.
Research focuses on functional gastrointestinal disorders, especially diarrhoea‑predominant irritable bowel syndrome.
The goal is to evaluate novel agents that provide symptom relief and improve quality of life.
The site conducts trials on hormone‑related hair loss in women, addressing androgenetic alopecia.
These studies assess oral minoxidil and topical formulations to restore hair density.
Investigations target joint pain and osteoarthritis, particularly in patients with excess weight.
Therapies aim to achieve pain reduction and enhance mobility while addressing obesity.
Neurological research includes obstructive sleep apnea and its impact on brain health.
Trials evaluate drugs and devices designed to improve sleep quality and lessen daytime fatigue.
Metabolic studies address overweight, obesity and type 2 diabetes, seeking effective weight‑loss solutions.
Research tests compounds that promote body‑weight reduction and improve glycaemic control.
Respiratory trials evaluate asthma therapies and vaccine candidates against viral infections.
The aim is to demonstrate efficacy of inhaled treatments and protective vaccine efficacy in older adults.
Skin research includes studies on hair loss and related connective‑tissue conditions.
Outcomes focus on hair count improvement and patient satisfaction.
The laboratory investigates viral pathogens, testing vaccines for influenza and respiratory syncytial virus.
These studies aim to protect high‑risk seniors and reduce severe respiratory illness.
Psychiatric research at the site evaluates botanical and non‑pharmacologic treatments for major depressive disorder.
The objective is to show symptom improvement and higher remission rates.
Clinical trials currently enrolling participants at this site.
Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
GermanyStudy on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure
GermanyA Phase 3 Randomized, Double-blind,Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Participants with Obstructive Sleep Apnea not on Positive Airway Pressure Therapy and Living with Overweight or Obesity (MARITIME-OSA-2)
GermanyEfficacy and safety of the investigational mRNA influenza vaccine gskvx000000077430 (drug combination) in adults ≥ 65 years
GermanyStudy of the efficacy and safety of Eloralintide in adults with knee osteoarthritis and overweight or obesity
GermanyA study to evaluate the effects of zenagamtide in people with overweight or obesity and obstructive sleep apnoea not treated with positive airway pressure
GermanyStudy of zenagamtide for weight loss and sleep improvement in patients with obesity and obstructive sleep apnea using positive airway pressure therapy
GermanyStudy of Maridebart Cafraglutide for Adults with Obstructive Sleep Apnea and Overweight or Obesity Who Use Positive Airway Pressure Therapy
GermanyA Study of Orforglipron for Knee Pain Relief in Adults with Obesity or Overweight and Knee Osteoarthritis
GermanyStudy on the Effectiveness and Safety of Myrrh, Coffee Charcoal, and Chamomile Extract for Patients with Diarrhea-Predominant Irritable Bowel Syndrome
GermanyEffect of laroprovstat/rosuvastatin combination versus laroprovstat, rosuvastatin, and placebo on LDL‑C in hypercholesterolemia patients not previously treated with lipid‑lowering therapy
GermanyPhase 3 Double‑Blind Study of Olatorepatide for Weight Loss in Adults with Overweight or Obesity Without Diabetes
GermanyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
